Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Vanguard Health Systems, Inc. (“Vanguard Health” or the “Company”) (NYSE: VHS) relating to the acquisition by Tenet Healthcare Corporation. (“Tenet”).
Click here to learn more about the investigation
, or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Vanguard Health shareholders will receive $21.00 in cash for each share of Vanguard Health stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Vanguard Health for not acting in the Company’s shareholders' best interests in connection with the sale process. The transaction may undervalue the Company as Vanguard Health had revenues of just under $6 billion. The merger between Tenet and Vanguard creates a larger company that can compete with much larger firms like HCA but denies Vanguard Health shareholders the opportunity to reap these benefits as they are being cashed out with out the opportunity to receive stock in the combined Company.
If you own shares of Vanguard Health common stock and wish to discuss the investigation or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at
, by visiting
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and case action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.